Cargando…
Clinical deep remission and related factors in a large cohort of patients with rheumatoid arthritis
BACKGROUND: Clinical remission is the treatment target in rheumatoid arthritis (RA). This study aimed to investigate clinical remission and related factors in a large cohort of patients with RA. METHODS: This study composed of 342 patients with RA. Data were collected by face-to-face interview of 10...
Autores principales: | Liu, Jia-Jia, Li, Ru, Gan, Yu-Zhou, Zhang, Rui-Jun, Li, Jing, Cai, Yue-Ming, Zhao, Jin-Xia, Liao, Hua, Xu, Jing, Shi, Lian-Jie, Li, Ji, Li, Sheng-Guang, Sun, Xiao-Lin, He, Jing, Liu, Xu, Ye, Hua, Li, Zhan-Guo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595890/ https://www.ncbi.nlm.nih.gov/pubmed/30946065 http://dx.doi.org/10.1097/CM9.0000000000000227 |
Ejemplares similares
-
Effect of sustained intensive therapy with disease modifying anti-rheumatic drugs in rheumatoid arthritis: a 5-year real-world consecutive study
por: Cai, Yue-Ming, et al.
Publicado: (2020) -
Glucose-6-phosphate isomerase is associated with disease activity and declines in response to infliximab treatment in rheumatoid arthritis
por: Xu, Jing, et al.
Publicado: (2020) -
The usage of biological DMARDs and clinical remission of rheumatoid arthritis in China: a real-world large scale study
por: An, Yuan, et al.
Publicado: (2016) -
Rheumatoid Arthritis: Defining Clinical and Ultrasound Deep Remission
por: Hèctor, Corominas, et al.
Publicado: (2020) -
High remission and low relapse with prolonged intensive DMARD therapy in rheumatoid arthritis (PRINT): A multicenter randomized clinical trial
por: Li, Ru, et al.
Publicado: (2016)